NFE2L2 and diabetes mellitus: Various studies have addressed therapies targeting the (Nrf2)/Kelch-like ECH-related protein 1 (Keap1)/Antioxidant Response (ARE) pathway is the principal inducible defense against oxidative stresses in various disease including diabetes mellitus (Baird and Yamamoto, 2020).